Pillar Clinical Research Revenue and Competitors
Estimated Revenue & Valuation
- Pillar Clinical Research's estimated annual revenue is currently $6.3M per year.
- Pillar Clinical Research's estimated revenue per employee is $91,800
Employee Data
- Pillar Clinical Research has 69 Employees.
- Pillar Clinical Research grew their employee count by 57% last year.
Pillar Clinical Research's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Operating Officer | Reveal Email/Phone |
3 | CFO | Reveal Email/Phone |
4 | Chief Experience Officer | Reveal Email/Phone |
5 | VP Training and Development | Reveal Email/Phone |
6 | VP Clinical Affairs | Reveal Email/Phone |
7 | Director Corporate Development | Reveal Email/Phone |
8 | Site Director/Psychometric Rater | Reveal Email/Phone |
9 | Site Director | Reveal Email/Phone |
10 | Director Recruiting | Reveal Email/Phone |
Pillar Clinical Research Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $2.9M | 36 | -16% | N/A | N/A |
#2 | $6M | 65 | 14% | N/A | N/A |
#3 | $1.8M | 25 | 0% | N/A | N/A |
#4 | $6.5M | 66 | 29% | N/A | N/A |
#5 | $1.5M | 21 | -12% | N/A | N/A |
#6 | $2.5M | 31 | -3% | N/A | N/A |
#7 | $1.7M | 24 | 33% | N/A | N/A |
#8 | $2.7M | 33 | -11% | N/A | N/A |
#9 | $8.5M | 83 | 20% | N/A | N/A |
#10 | $40.9M | 321 | 11% | N/A | N/A |
What Is Pillar Clinical Research?
Pillar Clinical Research, LLC provides expert & experienced conduct of Phase 1-4 clinical trials for both inpatient and outpatient studies. We are a multi-specialty clinical research group, with specialization in CNS indications: such as, but not limited to, schizophrenia, mood & anxiety disorders, PTSD, post-partum depression, addictions.
keywords:N/AN/A
Total Funding
69
Number of Employees
$6.3M
Revenue (est)
57%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Pillar Clinical Research News
$20M IHMC research facility could connect Pensacola's historic and ... That new pillar would mean the staff could study things such as how...
Carbone: [Immunotherapy] represents a new pillar of therapy available for treating patients with lung cancer. It started out in the second-...
Results of the validation study of Pillar's oncoReveal Dx Lung & Colon Cancer Assay established that this FDA-approved IVD assay can...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $9M | 69 | -9% | N/A |
#2 | $9M | 69 | -1% | N/A |
#3 | $15M | 70 | 19% | N/A |
#4 | $9.1M | 70 | 35% | N/A |
#5 | $9.1M | 70 | 35% | N/A |